Found 11 matching trials
IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases NA In this prospective controlled monocentric observational study, we assessed...
Show More Location
UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I. Medizinische Klinik und Poliklinik
Learn More & Join Trial
High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy PHASE2 The primary endpoint of this study is to determine what percentage of patie...
Show More Location
Multiple Locations
Learn More & Join Trial
Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) PHASE2 Primary Objectives:
* Part A: Efficacy of SAR445088 across three subpopula...
Show More Location
University of Southern California Site Number : 8400004
Learn More & Join Trial
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work PHASE3 The purpose of the study is to evaluate efficacy of riliprubart compared to...
Show More Status
Active Not Recruiting
Location
Alabama Neurology Associates- Site Number : 8400019
Learn More & Join Trial
The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies PHASE2 To evaluate the efficacy and safety of rituximab (genetical recombination) ...
Show More Location
Nagoya University Hospital
Learn More & Join Trial
A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP PHASE1 This is a multicenter, open-label, single-dose, dose-escalation study evalu...
Show More Location
Kangbuk Samsung Hospital
Learn More & Join Trial
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. EARLY_PHASE1 This is an open label, single-site, dose-escalation study in up to 25 parti...
Show More Location
Xuanwu Hospital, Capital Medical University
Learn More & Join Trial
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) N/A This study is designed as an explorative study aiming at exploring safety a...
Show More Location
University of Ulm
Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases PHASE1 This study will have two Phases: Phase 1a and Phase 1b. The goals of this c...
Show More Location
Hoag Memorial Hospital Presbyterian
Learn More & Join Trial
Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy NA This multicenter, randomized, controlled trial aims to evaluate the efficac...
Show More Status
Active Not Recruiting
Location
Sichuan Provincial People's Hospital
Learn More & Join Trial